Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Human DRAK1 Synthetic Peptide
Click to view available options
Quantity:
50 μg
Description
DRAK1 Synthetic Peptide, PEP-0051, from Invitrogen.
STK17A (DRAK1) is a serine/threonine kinase localized in the nucleus and involved in apoptosis. Diseases associated with STK17A include Colon Squamous Cell Carcinoma. Among its related pathways are Sweet Taste Signaling. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is STK17B.

Specifications
Specifications
Gene ID (Entrez) | 9263 |
Species | Human |
Purification Method | purified |
Accession Number | Q9UEE5 |
Common Name | Human DRAK1 |
Concentration | 200 μg/mL |
Content And Storage | -20°C |
Description | Synthetic Peptide |
Format | Liquid |
Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
Show More |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction